Quinolizidine alkaloids derivatives from Sophora alopecuroides Linn: Bioactivities, structure-activity relationships and preliminary molecular mechanisms

Y Li, G Wang, J Liu, L Ouyang - European Journal of Medicinal Chemistry, 2020 - Elsevier
Quinolizidine alkaloids, as essential active ingredients extracted from Sophora
alopecuroides Linn, have been well concerned in the past several decades owing to the …

Antidepressants and risk of sudden cardiac death: a network meta-analysis and systematic review

N Prasitlumkum, W Cheungpasitporn, N Tokavanich… - Medical …, 2021 - mdpi.com
Background: Antidepressants are one of the most prescribed medications, particularly for
patients with mental disorders. Nevertheless, there are still limited data regarding the risk of …

Association of antidepressant medication type with the incidence of cardiovascular disease in the ARIC study

Z Almuwaqqat, M Jokhadar, FL Norby… - Journal of the …, 2019 - Am Heart Assoc
Background The association of antidepressant medication type with the risk of
cardiovascular disease (CVD) is unclear. We hypothesized that selective serotonin reuptake …

Frequency, characteristics and nature of risk factors associated with use of QT interval prolonging medications and related drug-drug interactions in a cohort of …

B Das, VS Rawat, SK Ramasubbu, B Kumar - Therapies, 2019 - Elsevier
Quite a number of antipsychotic and antidepressant drugs are known to cause significant QT-
prolongation. Psychiatric patients constitute a population at notable risk of drug-induced QT …

Serious arrhythmia in initiators of citalopram, escitalopram, and other selective serotonin reuptake inhibitors: A population‐based cohort study in older adults

M Aakjær, SK Werther, ML De Bruin… - Clinical and …, 2022 - Wiley Online Library
The selective serotonin reuptake inhibitors (SSRIs) citalopram and escitalopram are
associated with QT prolongation, which increases the risk of serious arrhythmia …

Cardiovascular outcomes associated with clinical use of citalopram and omeprazole: a nationwide population‐based cohort study

WT Wu, CT Tsai, YC Chou, PM Ku… - Journal of the …, 2019 - Am Heart Assoc
Background Recent studies have raised concerns about the reduced efficacy of citalopram
when used concurrently with proton pump inhibitors. The aim of this study was to evaluate …

Associations of antidepressants with atrial fibrillation and ventricular arrhythmias: a systematic review and meta-analysis

Y Cao, M Zhou, H Guo, W Zhu - Frontiers in Cardiovascular Medicine, 2022 - frontiersin.org
Background Several published studies have disagreements on whether the use of
antidepressants is associated with increased risk of arrhythmias. In this study, we performed …

Comparison of the effect of citalopram, bupropion, sertraline, and tricyclic antidepressants on QTc: A cross-sectional study

CM Straley, M Sochacki, E Reed, CN Carr… - Journal of Affective …, 2022 - Elsevier
Background Some data suggests that citalopram has more risk of corrected QT interval
(QTc) prolongation than other selective serotonin reuptake inhibitors. Consequently the US …

Antidepressants and the risk of arrhythmia in elderly affected by a previous cardiovascular disease: a real-life investigation from Italy

A Biffi, F Rea, L Scotti, A Mugelli, E Lucenteforte… - European Journal of …, 2018 - Springer
Purpose The study aimed to fill existing knowledge gaps on the safety of antidepressant
drugs (ADs) by estimating the risk of hospitalization for arrhythmia associated with use of …

稳心颗粒联合胺碘酮对心肌梗死合并室性心律失常治疗效果及hs-CRP 水平的影响.

王月平, 李德平, 任星星, 杨红霞… - Progress in Modern …, 2020 - search.ebscohost.com
摘要目的: 探讨稳心颗粒联合胺碘酮对心肌梗死合并室性心律失常治疗效果及hs-CRP
水平的影响. 方法: 选取2017 年11 月至2019 年9 月我院84 例心肌梗死合并室性心律失常患者 …